Our ability to digitise the world around us now readily outstrips our ability to process the data we generate. 
Rob Baxter reports
Kevin McNulty, director of product marketing for life sciences at Intralinks, explores the technology behind secure collaboration within the life sciences industry
Gary Tyreman, CEO at Univa, reveals why users of open-source software crave the most support
Carlo Poloni, president of Esteco and Engineering Professor at University of Trieste, argues in favour of optimisation
Chemistry software will be split between expert tools for computational chemists and 3D desktop modelling tools to support the work of medicinal chemists, says Dr Martin Slater, director of consulting at Cresset
When it comes to buying a LIMS, theres a right way and a wrong way. Autoscribes founder and CEO, John Boother, explains
How do we tackle the problem of energy efficiency in HPC centres? Dr Giampietro Tecchiolli, Eurotech CTO, offers his thoughts
Multi-parameter optimisation (MPO) in drug discovery is an area thats had incredible uptake recently, says Matt Segall, Optibriums CEO. He explains why
An accelerator war is brewing on the horizon! Adaptive Computing CEO Rob Clyde casts his eyes over the field of battle
Self-service informatics solutions - are they really what theyre cracked up to be? Dr Stephen Gallagher, CEO at Dotmatics, shares his view
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
